Global Mammalian Cell Expression System Market Growth (Status and Outlook) 2023-2029

Global Mammalian Cell Expression System Market Growth (Status and Outlook) 2023-2029

The global Mammalian Cell Expression System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Mammalian Cell Expression System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Mammalian Cell Expression System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Mammalian Cell Expression System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Mammalian Cell Expression System players cover Thermo Fisher Scientific, Bio Basic, GenScript Biotech, Oxford Expression Technologies, ProteoGenix, Promab Biotechnologies, MTIBIO, AMSBIO and Kemp Proteins, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Mammalian cell expression system is a type of recombinant protein expression system that uses genetically modified mammalian cells to produce large amounts of specific proteins. Mammalian cells are a popular choice for protein expression because they have the ability to perform post-translational modifications such as glycosylation, phosphorylation, and disulfide bond formation, which are important for the biological activity and stability of many proteins. Mammalian cell expression systems are widely used in the production of recombinant proteins for research, therapeutic, and industrial applications. They offer high protein expression levels, produce proteins with correct post-translational modifications, and are suitable for the production of complex and difficult-to-express proteins.

LPI (LP Information)' newest research report, the “Mammalian Cell Expression System Industry Forecast” looks at past sales and reviews total world Mammalian Cell Expression System sales in 2022, providing a comprehensive analysis by region and market sector of projected Mammalian Cell Expression System sales for 2023 through 2029. With Mammalian Cell Expression System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mammalian Cell Expression System industry.

This Insight Report provides a comprehensive analysis of the global Mammalian Cell Expression System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mammalian Cell Expression System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mammalian Cell Expression System market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mammalian Cell Expression System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mammalian Cell Expression System.

This report presents a comprehensive overview, market shares, and growth opportunities of Mammalian Cell Expression System market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Chinese Hamster Ovary (CHO) Cells
Human Embryonic Kidney (HEK) Cells
Mouse Myeloma Cells
BHK-21 Cells
Others

Segmentation by application
Drugs Development
Biomedical Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Bio Basic
GenScript Biotech
Oxford Expression Technologies
ProteoGenix
Promab Biotechnologies
MTIBIO
AMSBIO
Kemp Proteins
Takara Bio
Genosphere Biotechnologies
Biocompare
Profacgen
Creative BioMart
Sino Biological
Hangzhou Clongene Biotech

Please note: The report will take approximately 2 business days to prepare and deliver.